Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

Alhossain A. Khalafallah; Bernadene Fernandopulle; Terry Brain

doi:10.4084/mjhid.2010.012

DOI https://doi.org/10.4084/mjhid.2010.012

PDF HTML

Published: May 31, 2010

Letters to Editor

Issue

Vol. 2 No. 2 (2010): New Drugs and Hemopoietic Stem Cell Transplantation in Oncohematological Diseases of the Elderly

Pages

e2010012

Keywords

Intermediate, high-risk MDS, IPSS, lenalidomide, hematological response, dose-modified.

Statistics

Abstract Views: 644

Share it

How to Cite

Khalafallah, A. A., Fernandopulle, B., & Brain, T. (2010). Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia. Mediterranean Journal of Hematology and Infectious Diseases, 2(2), e2010012. https://doi.org/10.4084/mjhid.2010.012

Alhossain A. Khalafallah

Launceston General Hospital, Australia.

Bernadene Fernandopulle

Launceston General Hospital, Tasmania, Australia.

Terry Brain

Launceston General Hospital, Tasmania, Australia.

(*) Corresponding Author:

Abstract

No Abstract Available

Downloads month by month

Downloads

Download data is not yet available.

Author Biographies

Alhossain A. Khalafallah, Launceston General Hospital

Department of Haematology and MedicineThe Launceston General HospitalCharles StreetLaunceston, TAS 7250Australia

Bernadene Fernandopulle, Launceston General Hospital, Tasmania

Department of Haematology and MedicineThe Launceston General HospitalCharles StreetLaunceston, TAS 7250Australia

Terry Brain, Launceston General Hospital, Tasmania

Department of Pathology,The Launceston General HospitalCharles StreetLaunceston, TAS 7250Australia

Most read articles by the same author(s)

Alhossain A. Khalafallah, Kristina McDonnell, Hizb U. Dawar, Iain Robertson, David Woods, QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION , Mediterranean Journal of Hematology and Infectious Diseases: Vol. 3 No. 1 (2011): Reviews, Articles, Case Reports and Letters
Sofia Omari, Alhossain A. Khalafallah, Mahmoud Ayesh, Ismail Matalka, Al- Raji Hadithi, HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA , Mediterranean Journal of Hematology and Infectious Diseases: Vol. 3 No. 1 (2011): Reviews, Articles, Case Reports and Letters
Alhossain A. Khalafallah, Zafreen Rahman, Kath Ogden, Terry Hannan, Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia , Mediterranean Journal of Hematology and Infectious Diseases: Vol. 4 No. 1 (2012): Reviews, Articles, Case Reports and Letters
Alhossain A. Khalafallah, Sie Wuong Loi, Sarah Love, Muhajir B. Mohamed, Rose Mace, Ramy Khalil, Miriam Girgs, Rajesh Raj, Mathew Mathew, EARLY APPLICATION OF HIGH CUT-OFF HAEMODYALISIS FOR DE-NOVO MYELOMA NEPHROPATHY IS ASSOCIATED WITH LONG-TERM DIALYSIS-INDEPENDENCY AND RENAL RECOVERY , Mediterranean Journal of Hematology and Infectious Diseases: Vol. 5 No. 1 (2013): Reviews, Articles, Case Reports and Letters
Alhossain A. Khalafallah, Matthias Maiwald, Amanda Cox, Burns Denise, Gerald Bates, Terry Hannan, David Seaton, Bernadene Fernandopulle, Terry Brain, Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or Treated with Immunomodulatory Agents , Mediterranean Journal of Hematology and Infectious Diseases: Vol. 2 No. 1 (2010): Reviews on HCV, EBV and others.

Article Sidebar

Main Article Content